DeepDR: an integrated deep-learning model web server for drug repositioning

• URL: http://arxiv.org/abs/2511.08921v1
• Date: Thu, 13 Nov 2025 01:18:02 GMT
• Title: DeepDR: an integrated deep-learning model web server for drug repositioning
• Authors: Shuting Jin, Yi Jiang, Yimin Liu, Tengfei Ma, Dongsheng Cao, Leyi Wei, Xiangrong Liu, Xiangxiang Zeng,
• Abstract summary: We introduce DeepDR, the first integrated platform that combines a variety of established deep learning models for disease- and target-specific drug repositioning tasks.<n>The recommended results include detailed descriptions of the recommended drugs and visualize key patterns with interpretability through a knowledge graph.
• Score: 27.366843547451225
• License: http://creativecommons.org/licenses/by-nc-sa/4.0/
• Abstract: Background: Identifying new indications for approved drugs is a complex and time-consuming process that requires extensive knowledge of pharmacology, clinical data, and advanced computational methods. Recently, deep learning (DL) methods have shown their capability for the accurate prediction of drug repositioning. However, implementing DL-based modeling requires in-depth domain knowledge and proficient programming skills. Results: In this application, we introduce DeepDR, the first integrated platform that combines a variety of established DL-based models for disease- and target-specific drug repositioning tasks. DeepDR leverages invaluable experience to recommend candidate drugs, which covers more than 15 networks and a comprehensive knowledge graph that includes 5.9 million edges across 107 types of relationships connecting drugs, diseases, proteins/genes, pathways, and expression from six existing databases and a large scientific corpus of 24 million PubMed publications. Additionally, the recommended results include detailed descriptions of the recommended drugs and visualize key patterns with interpretability through a knowledge graph. Conclusion: DeepDR is free and open to all users without the requirement of registration. We believe it can provide an easy-to-use, systematic, highly accurate, and computationally automated platform for both experimental and computational scientists.

Related papers

• KITE-DDI: A Knowledge graph Integrated Transformer Model for accurately predicting Drug-Drug Interaction Events from Drug SMILES and Biomedical Knowledge Graph [0.11049608786515838]
  Drug-Drug Interactions (DDI) can cause significant bodily injury and even death.<n>Most contemporary research for predicting DDI events relies on either information from Biomedical Knowledge graphs (KG) or drug SMILES.<n>In this study, we propose a KG-integrated Transformer architecture to generate an end-to-end fully automated Machine Learning pipeline.
  arXiv  Detail & Related papers  (2024-12-08T00:49:57Z)
• Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural Network with Biomedical Network [69.16939798838159]
  We propose EmerGNN, a graph neural network (GNN) that can effectively predict interactions for emerging drugs. EmerGNN learns pairwise representations of drugs by extracting the paths between drug pairs, propagating information from one drug to the other, and incorporating the relevant biomedical concepts on the paths. Overall, EmerGNN has higher accuracy than existing approaches in predicting interactions for emerging drugs and can identify the most relevant information on the biomedical network.
  arXiv  Detail & Related papers  (2023-11-15T06:34:00Z)
• Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction [43.5957881547028]
  Recent advances in artificial intelligence (AI) as well as deep and graph learning models have established their usefulness in biomedical applications. DDIs refer to a change in the effect of one drug to the presence of another drug in the human body. To correctly apply the advanced AI and deep learning, the developer and user meet various challenges such as the availability and encoding of data resources.
  arXiv  Detail & Related papers  (2023-06-08T14:54:50Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• RECOMED: A Comprehensive Pharmaceutical Recommendation System [8.681590862953623]
  A pharmaceutical recommendation system was designed based on the patients and drugs features extracted from Drugs.com and Druglib.com. To the best of our knowledge, we are the first group to consider patients conditions and history in the proposed approach for selecting a specific medicine appropriate for that particular user.
  arXiv  Detail & Related papers  (2022-12-31T20:04:31Z)
• Medical Knowledge Graph QA for Drug-Drug Interaction Prediction based on Multi-hop Machine Reading Comprehension [18.34651382394962]
  This paper presents a medical knowledge graph question answering model, dubbed MedKGQA. It predicts drug-drug interaction by employing machine reading comprehension from closed-domain literature and constructing a knowledge graph of drug-protein triplets from open-domain documents. The proposed model achieved a 4.5% improvement in terms of drug-drug interaction prediction accuracy compared to previous state-of-the-art models on the Qangaroo MedHop dataset.
  arXiv  Detail & Related papers  (2022-12-19T12:24:32Z)
• ImDrug: A Benchmark for Deep Imbalanced Learning in AI-aided Drug Discovery [79.08833067391093]
  Real-world pharmaceutical datasets often exhibit highly imbalanced distribution. We introduce ImDrug, a benchmark with an open-source Python library which consists of 4 imbalance settings, 11 AI-ready datasets, 54 learning tasks and 16 baseline algorithms tailored for imbalanced learning. It provides an accessible and customizable testbed for problems and solutions spanning a broad spectrum of the drug discovery pipeline.
  arXiv  Detail & Related papers  (2022-09-16T13:35:57Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)
• Deep learning for drug repurposing: methods, databases, and applications [54.08583498324774]
  Repurposing existing drugs for new therapies is an attractive solution that accelerates drug development at reduced experimental costs. In this review, we introduce guidelines on how to utilize deep learning methodologies and tools for drug repurposing.
  arXiv  Detail & Related papers  (2022-02-08T09:42:08Z)
• A Review of Biomedical Datasets Relating to Drug Discovery: A Knowledge Graph Perspective [4.746544835197422]
  We aim to help guide machine learning and knowledge graph practitioners who are interested in applying new techniques to the drug discovery field. We detail publicly available primary data sources containing information suitable for use in constructing various drug discovery focused knowledge graphs.
  arXiv  Detail & Related papers  (2021-02-19T17:49:38Z)
• DeepPurpose: a Deep Learning Library for Drug-Target Interaction Prediction [69.7424023336611]
  DeepPurpose is a comprehensive and easy-to-use deep learning library for DTI prediction. It supports training of customized DTI prediction models by implementing 15 compound and protein encoders and over 50 neural architectures. We demonstrate state-of-the-art performance of DeepPurpose on several benchmark datasets.
  arXiv  Detail & Related papers  (2020-04-19T17:31:55Z)
• DeepEnroll: Patient-Trial Matching with Deep Embedding and Entailment Prediction [67.91606509226132]
  Clinical trials are essential for drug development but often suffer from expensive, inaccurate and insufficient patient recruitment. DeepEnroll is a cross-modal inference learning model to jointly encode enrollment criteria (tabular data) into a shared latent space for matching inference.
  arXiv  Detail & Related papers  (2020-01-22T17:51:25Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.